The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Reasons for delay in time to initiation of adjuvant chemotherapy (AC) for colon cancer (CC).
David Warren Wasserman
No relevant relationships to disclose
Christopher M. Booth
No relevant relationships to disclose
Wilma Hopman
No relevant relationships to disclose
Abdullah Al Sharm
No relevant relationships to disclose
James Joseph Biagi
No relevant relationships to disclose